Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- lonapegsomatropin
- Macrilen (macimorelin)
Interactions between your drugs
macimorelin lonapegsomatropin
Applies to: Macrilen (macimorelin), lonapegsomatropin
Lonapegsomatropin may affect the accuracy of the diagnostic test performed with macimorelin. It is generally recommended to discontinue lonapegsomatropin for a washout period before administration of the test. Talk to a healthcare professional if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
macimorelin food
Applies to: Macrilen (macimorelin)
Food may interfere with the absorption of macimorelin, which may lead to false positive test results. You should fast for at least 8 hours before taking macimorelin.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Growth hormones
Therapeutic duplication
The recommended maximum number of medicines in the 'growth hormones' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'growth hormones' category:
- lonapegsomatropin
- Macrilen (macimorelin)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ngenla
Ngenla is a long-acting human growth hormone used to treat children aged 3 and older who are not ...
Humatrope
Humatrope injection (somatropin) is a human growth hormone used to treat growth failure in children ...
Sogroya
Sogroya information from Drugs.com, includes Sogroya side effects, interactions and indications.
Genotropin
Genotropin is a human growth hormone used to treat growth failure in children and adults who lack ...
Norditropin
Norditropin is used to treat growth hormone deficiency (GHD) in adults and children and other ...
Omnitrope
Omnitrope (somatropin) is a form of human growth hormone used to treat adults and children with ...
Norditropin FlexPro
Norditropin FlexPro is used for adult human growth hormone deficiency, idiopathic short stature ...
Skytrofa
Skytrofa injection is a once-weekly, slow-release human growth hormone (lonapegsomatropin) ...
Nutropin
Nutropin is used for adult human growth hormone deficiency, growth retardation, chronic renal ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.